Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Euro-Diagnostica AB — Predicate Candidate Screening
6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
175 daysmedian FDA review time
344 days90th percentile
6clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K093908 | CCPOINT | Euro-Diagnostica AB | 2010-12-01 | 344 | 0 |
| K091657 | IMMUNOSCAN CCPLUS | Euro-Diagnostica AB | 2009-11-19 | 163 | 1 |
| K062045 | EDIA ANTI-CCP | Euro-Diagnostica AB | 2006-12-04 | 138 | 0 |
| K971690 | IMMUNOSCAN PR3-ANCA | Euro-Diagnostica AB | 1997-10-29 | 175 | 0 |
| K971464 | IMMUNOSCAN ANTI-GBM QUANTITATIVE KIT | Euro-Diagnostica AB | 1997-10-29 | 190 | 0 |
| K971689 | IMMUNOSCAN ANTI-MYELOPEROXIDASE ANTIBODIES (MPO-ANCA) QUANTI | Euro-Diagnostica AB | 1997-10-29 | 175 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda